Under section 38 of the Pharmacy and Poisons Ordinance (Cap. 138), advertisements for medicines must not contain false or misleading content or promote unapproved therapeutic claims. Cross-border e-commerce sellers must ensure that all advertising complies with the requirements of the Hong Kong Drug Office and must not directly or indirectly promote prescription medicines to the public. Rengangyongsheng (Hong Kong) Limited recommends that sellers work with a professional compliance team to review advertising content and ensure that promotional copy meets regulatory requirements, avoiding regulatory penalties for non-compliant advertising.
HONG KONG DRUG LICENSING
How can Hong Kong sellers ensure that their pharmaceutical advertisements comply with local regulations when selling through cross-border e-commerce?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions